Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Susceptibility breakpoint for Danofloxacin against swine Escherichia coli

4 Feb 2019

Abstract excerpt

Improper use of antimicrobials results in poor treatment and severe bacterial resistance. Breakpoints are routinely used in the clinical laboratory setting to guide clinical decision making. Therefore, the objective of this study was to establish antimicrobial susceptibility breakpoints for danofloxacin against Escherichia coli ( E.coli ), which is an important pathogen of digestive tract infections. The minimum...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Bacterial Identification and Susceptibility Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30717803
DOI: 10.1186/s12917-019-1783-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Susceptibility breakpoint for Danofloxacin against swine Escherichia coliPMID 30717803Read ↗

Evaluation the kill rate and mutant selection window of danofloxacin against Actinobacillus pleuropneumoniae in a peristaltic pump model.Semantic proximity Read ↗

In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.Semantic proximity Read ↗

Setting and Revising Antibacterial Susceptibility BreakpointsSemantic proximity Read ↗

Don't Get Wound Up: Revised Fluoroquinolone Breakpoints for Enterobacteriaceae and Pseudomonas aeruginosaSemantic proximity Read ↗

Comparative Efficacies Of Current Second And Third Generation Fluoroquinolone Antibiotics On Systemic Escherichia Coli In Broiler Chickens In Qalyubia FarmsSemantic proximity Read ↗

In vitro bactericidal activity of enrofloxacin against gyrA mutant and qnr-containing Escherichia coli isolates from animals.Semantic proximity Read ↗

Analysis of the mutant selection window and killing of Mycoplasma hyopneumoniae for doxycycline, tylosin, danofloxacin, tiamulin, and valnemulin.Semantic proximity Read ↗

Concentration-resistance relationship and PK/PD evaluation of danofloxacin against emergence of resistant Pasteurella multocida in an in vitro dynamic model.Semantic proximity Read ↗

Mutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves.Semantic proximity Read ↗

Use of the D-R model to define trends in the emergence of Ceftazidime-resistant Escherichia coli in China.Semantic proximity Read ↗

Comparison of the Minimum Inhibitory and Mutant Prevention Drug Concentrations for Pradofloxacin and 7 Other Antimicrobial Agents Tested Against Swine Isolates of Actinobacillus pleuropneumoniae and Pasteurella multocida.Semantic proximity Read ↗

Comparative mutant prevention concentration and antibacterial activity of fluoroquinolones against Escherichia coli in diarrheic buffalo calves.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.